Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2/3 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Follicular 2Lymphoma 2Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1Burkitt Lymphoma 1

Interventions

Rituximab 59Cyclophosphamide 35Vincristine 28Doxorubicin 24Prednisone 22Bendamustine Hydrochloride 17Etoposide 15Radiotherapy 12Cytarabine 10Peripheral Blood Stem Cell Transplantation 8Filgrastim 8ibrutinib 7VAP-cyclo protocol 7Prednisolone 7Methotrexate 7Granulocyte Colony-Stimulating Factor 7ibritumomab tiuxetan 6fludarabine 6Melphalan 6Gemcitabine 6pirtobrutinib 5Mitoxantrone 5Lenalidomide 5Carmustine 5Bleomycin 5pixantrone 4Mycophenolic Acid 4Methylprednisolone 4Ifosfamide 4Idarubicin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Lymphoma, Non-Hodgkin × epratuzumab × Clear all
NCT00003337 2021-08-16

Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma

Gilead Sciences

Phase 3 Unknown
100 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡